Real-time enrollment status for this metastatic breast cancer clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 7:41 AM UTC
| NCT Number | NCT05508906 |
| Recruiting Status | Recruiting |
| Condition | Metastatic Breast Cancer |
| Phase | Clinical Trial |
| Target Enrollment | 190 participants |
| Active Locations | 14 sites in the US |
| Sponsor | Olema Pharmaceuticals, Inc. |
| Last Updated on CT.gov | October 22, 2025 (Oct 22, 2025) |
As of July 13, 2026: Clinical trial NCT05508906 is currently recruiting participants. This clinical trial study for metastatic breast cancer is actively seeking new participants at 14 locations across the United States. The study is sponsored by Olema Pharmaceuticals, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05508906 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 14 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05508906 was last updated Oct 22, 2025 (October 22, 2025). HelloStudys verifies this status automatically.